A large US-multicenter trial conducted by Tzartzeva et al. comprising 13.367 patients demonstrated that the poor sensitivity of ultrasound alone (47%) in detection of early-stage HCC could be significantly enhanced by additional AFP determination (63%) [7]. The gene discussed is AFP; the disease is hepatocellular carcinoma.